CRISPR Journal

Papers
(The median citation count of CRISPR Journal is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells408
Establishing CRISPR-Cas Technology in Pakistan58
The CRISPR Chronicles and the Power of Storytelling45
Exploring the Cytoplasmic Retention of CRISPR-Cas9 in Eukaryotic Cells: The Role of Nuclear Localization Signals and Ribosomal Interactions41
A Field Day for Gene-Edited Brassicas and Crop Improvement38
Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas1336
Search for Origins of Anti-CRISPR Proteins by Structure Comparison35
Correction to: Human Germline and Heritable Genome Editing: The Global Policy Landscape by Baylis et al. The CRISPR Journal 2020;3(5): 365–377; DOI: 10.1089/crispr.2020.008233
Deep Sequencing Reveals the Comprehensive CRISPR-Cas9 Editing Spectrum in Bombyx mori31
Increasing Genome Editing Efficiency of Cas9 Nucleases by the Simultaneous Use of Transcriptional Activators and Histone Acetyltransferase Activator31
CRISPR and the Plant Pathologists' Holy Grail29
Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for The CRISPR Journal29
Transversion Expansion of Base Editing28
Special Issue: CRISPR's Path to the Clinic26
What if Bacteria Could Tell Us What They Have Seen?25
A CRISPR Landing for Genome Rewriting at Locus-Scale25
Spotlight on Genetic Design in a Spotted Wing Crop Killer24
Model System to Analyze RNA-Mediated DNA Repair in Mammalian Cells24
Functional and Phylogenetic Diversity of Cas10 Proteins23
Modified Cas9-Guided Oxford Nanopore Technology Sequencing Uncovers Single and Multiple Transgene Insertion Sites in a Zebrafish Melanoma Model22
CRISPR Milestones for Sustainable Agriculture and Forestry22
Reprogramming of Human B Cells from Secreting IgG to IgM by Genome Editing21
A Protein-Cutting CRISPR Complex Caught in Action21
It's a Knockout for Cat Allergies?21
Structural Investigation of Self-Assembly and Target Binding of Anti-CRISPR AcrIIC219
CRISPR Adventures in China19
Pseudogene-Mediated Gene Conversion After CRISPR-Cas9 Editing Demonstrated by Partial CD33 Conversion with SIGLEC22P18
APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels18
Adaptation by Type V-A and V-B CRISPR-Cas Systems Demonstrates Conserved Protospacer Selection Mechanisms Between Diverse CRISPR-Cas Types16
Prime Editing in Mammals: The Next Generation of Precision Genome Editing16
Efficient Generation of SOCS2 Knock-Out Sheep by Electroporation of CRISPR-Cas9 Ribonucleoprotein Complex with Dual-sgRNAs14
CRISPR Comparison Toolkit: Rapid Identification, Visualization, and Analysis of CRISPR Array Diversity14
Cas12a-Capture: A Novel, Low-Cost, and Scalable Method for Targeted Sequencing13
Rationally Designed Base Editors for Precise Editing of the Sickle Cell Disease Mutation13
Optimization of Genomewide CRISPR Screens Using AsCas12a and Multi-Guide Arrays13
A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy12
The CRISPR Revolution in the Drug Discovery Workflow: An Industry Perspective12
Locus-Specific Genomic DNA Purification Using the CRISPR System: Methods and Applications12
GOANA: A Universal High-Throughput Web Service for Assessing and Comparing the Outcome and Efficiency of Genome Editing Experiments12
CRISPRa-Mediated Upregulation of scn1laa During Early Development Causes Epileptiform Activity and dCas9-Associated Toxicity11
Induction and Elimination of Prophages Using CRISPR Interference11
Allele-Specific Inactivation of an Autosomal Dominant Epidermolysis Bullosa Simplex Mutation Using CRISPR-Cas911
High-Throughput Imaging of CRISPR- and Recombinant Adeno-Associated Virus–Induced DNA Damage Response in Human Hematopoietic Stem and Progenitor Cells11
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for The CRISPR Journal10
Bacterial Retrons Enable Precise Gene Editing in Human Cells10
First Drug Approval Rises the CRISPR Tide10
Warrior Spirit: An Interview with Victoria Gray, Sickle Cell Pioneer10
Hairpin Internal Nuclear Localization Signals in CRISPR-Cas9 Enhance Editing in Primary Human Lymphocytes9
Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient9
CRISPR-Cas9-Mediated Correction of TSC2 Pathogenic Variants in iPSCs from Patients with Tuberous Sclerosis Complex Type 29
ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected9
Viral Delivery of Compact CRISPR-Cas12f for Gene Editing Applications9
Initial Characterization of 12 New Subtypes and Variants of Type V CRISPR Systems8
Auditing the Editor: A Review of Key Translational Issues in Epigenetic Editing8
Dead Cas9–sgRNA Complex Shelters Vulnerable DNA Restriction Enzyme Sites from Cleavage for Cloning Applications8
Inference of CRISPR Edits from Sanger Trace Data8
The CRISPR Patent Landscape: Focus on Chinese Researchers8
Navigating Viral Space with CRISPR Technologies8
Expression of Cas9 in a Syngeneic Model of Primary Central Nervous System Lymphoma Induces Intracerebral NK and CD8 T Cell-Mediated Lymphoma Cell Lysis Via Perforin8
A CRISPR-dCas9 System for Assaying and Selecting for RNase III Activity In Vivo in Escherichia coli8
Gene Editing and Rett Syndrome: Does It Make the Cut?8
Challenging the Boundaries Between Treatment, Prevention, and Enhancement in Human Genome Editing7
Increasing Gene Editing Efficiency for CRISPR-Cas9 by Small RNAs in Pluripotent Stem Cells7
Correction to: Genotyping MUltiplexed-Sequencing of CRISPR-Localized Editing (GMUSCLE): An Experimental and Computational Approach for Analyzing CRISPR-Edited Cells by Zhang et al. The CRISP7
Curing “GFP-itis” in Bacteria with Base Editors: Development of a Genome Editing Science Program Implemented with High School Biology Students7
Clinical Milestone for CRISPR Medicines7
Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability7
Correction to: Clonally Selected Lines After CRISPR-Cas Editing Are Not Isogenic by Panda et al. The CRISPR Journal, 2023;6(2):176–182; DOI: 10.1089/crispr.2022.00507
Green Fluorescent Protein Tagged Polycistronic Reporter System Reveals Functional Editing Characteristics of CRISPR-Cas6
Genetic Manipulation of a CAST of Characters in a Microbial Community6
Gene-Edited Fluorescent and Mixed Cerebral Organoids6
Enhancing Precision and Efficiency of Cas9-Mediated Knockin Through Combinatorial Fusions of DNA Repair Proteins6
A Taxonomic and Phylogenetic Classification of Diverse Base Editors6
Vulnerability and the Ethics of Human Germline Genome Editing6
Correction to: Programmable RNA Targeting Using CasRx in Flies, by Buchman, et al. The CRISPR Journal 2020;3(3)164–176; doi: 10.1089/crispr.2020.00186
Base Editors Flex Sights on Sickle-Cell Disease6
Universal Gene Correction Approaches for β-hemoglobinopathies Using CRISPR-Cas9 and Adeno-Associated Virus Serotype 6 Donor Templates6
Acknowledgment of Reviewers 20226
Acknowledgment of Reviewers 20236
Five Years of Progress in CRISPR Clinical Trials (2019–2024)5
CALITAS: A CRISPR-Cas-aware ALigner for In silico off-TArget Search5
Acknowledgment of Reviewers 20245
Regulatory Considerations for Clinical Trial Applications with CRISPR-Based Medicinal Products5
Comparison of Gene-Editing Approaches for Severe Congenital Neutropenia-Causing Mutations in the ELANE Gene5
Correction to: A Fluorescent Reporter Mouse for In Vivo Assessment of Genome Editing with Diverse Cas Nucleases and Prime Editors by Chen et al. The CRISPR Journal, 2023;6(6):570–582; DO5
Efficient and Economical Targeted Insertion in Plant Genomes via Protoplast Regeneration5
Discovery of Diverse CRISPR Leader Motifs, Putative Functions, and Applications for Enhanced CRISPR Detection and Subtype Annotation5
CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease In Vivo5
The DNA-Dialogue: A Broad Societal Dialogue About Human Germline Genome Editing in the Netherlands5
Editing Properties of Base Editors with SpCas9-NG in Discarded Human Tripronuclear Zygotes5
Increasing Knockin Efficiency in Mouse Zygotes by Transient Hypothermia5
CLASH of the Titans: How CAR-T Cells Can Triumph Over Tumors5
Impact of KIT Editing on Coat Pigmentation and Fresh Meat Color in Yorkshire Pigs5
Advances in Cas12a-Based Amplification-Free Nucleic Acid Detection5
Novel CRISPR-Associated Gene-Editing Systems Discovered in Metagenomic Samples Enable Efficient and Specific Genome Engineering5
CRISPR Hits Home in a First-in-Human Study5
Miniature CRISPR-Cas12f1-Mediated Single-Nucleotide Microbial Genome Editing Using 3′-Truncated sgRNA4
Genome Editing Therapy for the Blood: Ex Vivo Success and In Vivo Prospects4
Microfluidic Enrichment and Computational Analysis of Rare Sequences from Mixed Genomic Samples for Metagenomic Mining4
New Editing Tools for Gene Therapy in Inherited Retinal Dystrophies4
Genotyping MUltiplexed-Sequencing of CRISPR-Localized Editing (GMUSCLE): An Experimental and Computational Approach for Analyzing CRISPR-Edited Cells4
Early Detection of Wildlife Disease Pathogens Using CRISPR-Cas System Methods4
Efficient C-to-G Base Editing with Improved Target Compatibility Using Engineered Deaminase–nCas9 Fusions4
Rapid Variant Pathogenicity Analysis by CRISPR Activation of CRB1 Gene Expression in Patient-Derived Fibroblasts4
Multiplex Gene Tagging with CRISPR-Cas9 for Live-Cell Microscopy and Application to Study the Role of SARS-CoV-2 Proteins in Autophagy, Mitochondrial Dynamics, and Cell Growth4
CRISPR-AsCas12a Efficiently Corrects a GPR143 Intronic Mutation in Induced Pluripotent Stem Cells from an Ocular Albinism Patient4
Determination of Factors Driving the Genome Editing Field in the CRISPR Era Using Bibliometrics4
CASPER: An Integrated Software Platform for Rapid Development of CRISPR Tools4
Repurposing an Endogenous CRISPR-Cas System to Generate and Study Subtle Mutations in Bacteriophages4
Gene Editing of Checkpoint Molecules in Cord Blood-Derived Dendritic Cells and CD8+ T Cells Using CRISPR-Cas94
Measuring the Impact of Genetic Heterogeneity and Chromosomal Inversions on the Efficacy of CRISPR-Cas9 Gene Drives in Different Strains of Anopheles gambiae4
Sensitive and Easy-Read CRISPR Strip for COVID-19 Rapid Point-of-Care Testing4
Generation of a Commercial-Scale Founder Population of Porcine Reproductive and Respiratory Syndrome Virus Resistant Pigs Using CRISPR-Cas4
Give Cas a Chance: An Actionable Path to a Platform for CRISPR Cures4
Breaking the Rules4
Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells4
Response to Cook et al. re: Novel Off-Targeting Events Identified After Genome Wide Analysis of CRISPR-Cas Edited Pig4
Natural Nucleoside Modifications in Guide RNAs Can Modulate the Activity of the CRISPR-Cas9 System In Vitro3
Germline Editing of Drosophila Using CRISPR-Cas9-Based Cytosine and Adenine Base Editors3
CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa3
A Novel System for Simple Rapid Adenoviral Vector Construction to Facilitate CRISPR/Cas9-Mediated Genome Editing3
Establishment of a Cleavage-Based Single-Plasmid Dual-Luciferase Surrogate Reporter for the Cleavage Efficiency Evaluation of CRISPR-Cas12a Systems and Its Primary Application3
Identification and Evolution of Cas9 tracrRNAs3
CRISPR-Mediated Synergistic Epigenetic and Transcriptional Control3
Catalytically Enhanced Cas9 Through Directed Protein Evolution3
Insertion of the Icelandic Mutation (A673T) by Prime Editing: A Potential Preventive Treatment for Familial and Sporadic Alzheimer's Disease3
Base Editing of Somatic Cells Using CRISPR–Cas9 in Drosophila3
Predicting Mutations Generated by Cas9, Base Editing, and Prime Editing in Mammalian Cells3
Increasing the Targeting Scope of CRISPR Base Editing System Beyond NGG3
Optimizing Integration and Expression of Transgenic Bruton's Tyrosine Kinase for CRISPR-Cas9-Mediated Gene Editing of X-Linked Agammaglobulinemia3
A Novel Set of Cas9 Fusion Proteins to Stimulate Homologous Recombination: Cas9-HRs3
gEL DNA: A Cloning- and Polymerase Chain Reaction–Free Method for CRISPR-Based Multiplexed Genome Editing3
Strategies and Protocols for Optimized Genome Editing in Potato3
Special Issue: CRISPR Trials2
The CRISPR Toolbox: The End of the Beginning2
Reduction of Pre-Existing Adaptive Immune Responses Against SaCas9 in Humans Using Epitope Mapping and Identification2
CRISPR-Cas9-Mediated Gene Editing of MYB28 Genes Impair Glucoraphanin Accumulation of Brassica oleracea in the Field2
Enhanced Taq Variant Enables Efficient Genome Editing Testing and Mutation Detection2
Diverse Class 2 CRISPR Effectors as Active Nucleases with Expanded Targeting Capabilities2
CRISPR Gets Its Origin Story2
Functional Study of the Type II-A CRISPR-Cas System of Streptococcus agalactiae Hypervirulent Strains2
Enhanced Myogenesis by Silencing Myostatin with Nonviral Delivery of a dCas9 Ribonucleoprotein Complex2
Genome Editing Headwinds: Can CRISPR Stay on Target?2
CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia2
Bio-Orthogonal Chemistry Conjugation Strategy Facilitates Investigation of N-methyladenosine and Thiouridine Guide RNA Modifications on CRISPR Activity2
As CRISPR Technologies Ripen, What Should We Prioritize?2
Implementing CRISPR-Cas9 Yeast Practicals into Biology Curricula2
Unveiling Off-Target Mutations in CRISPR Guide RNAs: Implications for Gene Region Specificity2
WHO: Are You Ready for Human Genome Editing?2
Discovery and Characterization of Novel Type V Cas12f Nucleases with Diverse Protospacer Adjacent Motif Preferences2
Multiplex gRNAs Synergically Enhance Detection of SARS-CoV-2 by CRISPR-Cas12a2
Cas4–Cas1 Is a Protospacer Adjacent Motif–Processing Factor Mediating Half-Site Spacer Integration During CRISPR Adaptation2
A Novel CRISPR Interference Effector Enabling Functional Gene Characterization with Synthetic Guide RNAs2
CRISPR Crops and Sustainable Agriculture2
0.20234680175781